Literature DB >> 26951836

B Cells Promote Pancreatic Tumorigenesis.

Ali Roghanian1, Christopher Fraser2, Marianna Kleyman2, Jianzhu Chen3.   

Abstract

Three recent studies, approaching the question from different angles and using different and/or overlapping models, provide compelling evidence for the involvement of tumor-infiltrating B cells in the initiation and progression of pancreatic ductal adenocarcinoma. These studies highlight the need for a better understanding of pancreatic tumor-immune system interactions and the immunologic mechanisms that promote or inhibit tumorigenesis, paving the way for better treatment strategies. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 26951836     DOI: 10.1158/2159-8290.CD-16-0100

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  21 in total

1.  Leveraging premalignant biology for immune-based cancer prevention.

Authors:  Avrum Spira; Mary L Disis; John T Schiller; Eduardo Vilar; Timothy R Rebbeck; Rafael Bejar; Trey Ideker; Janine Arts; Matthew B Yurgelun; Jill P Mesirov; Anjana Rao; Judy Garber; Elizabeth M Jaffee; Scott M Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-16       Impact factor: 11.205

2.  Inhibiting PI3 kinase-γ in both myeloid and plasma cells remodels the suppressive tumor microenvironment in desmoplastic tumors.

Authors:  Xueqiong Zhang; Limei Shen; Qi Liu; Lin Hou; Leaf Huang
Journal:  J Control Release       Date:  2019-07-29       Impact factor: 9.776

Review 3.  The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions.

Authors:  Cameron J Herting; Isaac Karpovsky; Gregory B Lesinski
Journal:  Cancer Metastasis Rev       Date:  2021-09       Impact factor: 9.264

4.  Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response.

Authors:  Yonghua Cai; Ke Li; Jie Lin; Xianqiu Liang; Wei Xu; Zhengming Zhan; Shuaishuai Xue; Yu Zeng; Peng Chai; Yangqi Mao; Zibin Song; Lei Han; Ye Song; Xian Zhang; Hai Wang
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

5.  Pancreatic Tumor Microenvironment.

Authors:  Kai Wang; Hong He
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  PD-1 Shapes B Cells as Evildoers in the Tumor Microenvironment.

Authors:  Zhenhua Ren; Hua Peng; Yang-Xin Fu
Journal:  Cancer Discov       Date:  2016-05       Impact factor: 39.397

7.  Tumour microenvironment and heterotypic interactions in pancreatic cancer.

Authors:  Raúl Muñoz Velasco; Ana García García; Paula Jiménez Sánchez; Inmaculada Montanuy Sellart; Víctor Javier Sánchez-Arévalo Lobo
Journal:  J Physiol Biochem       Date:  2022-02-01       Impact factor: 4.158

8.  Precancer Atlas to Drive Precision Prevention Trials.

Authors:  Avrum Spira; Matthew B Yurgelun; Ludmil Alexandrov; Anjana Rao; Rafael Bejar; Kornelia Polyak; Marios Giannakis; Ali Shilatifard; Olivera J Finn; Madhav Dhodapkar; Neil E Kay; Esteban Braggio; Eduardo Vilar; Sarah A Mazzilli; Timothy R Rebbeck; Judy E Garber; Victor E Velculescu; Mary L Disis; Douglas C Wallace; Scott M Lippman
Journal:  Cancer Res       Date:  2017-04-01       Impact factor: 13.312

Review 9.  Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.

Authors:  Divya Murthy; Kuldeep S Attri; Pankaj K Singh
Journal:  Front Physiol       Date:  2018-04-04       Impact factor: 4.566

Review 10.  p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation.

Authors:  Kai Wang; Graham S Baldwin; Mehrdad Nikfarjam; Hong He
Journal:  World J Gastroenterol       Date:  2018-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.